Skip to main content
Premium Trial:

Request an Annual Quote

Norgen Biotek Developing POC MDx Technologies with $821K Award

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canadian biotechnology firm Norgen Biotek today announced a C$800,000 (US$821,000) award from the National Research Council of Canada Industrial Research Assistance Program, which the company will use to develop point-of-care diagnostic technologies.

The technologies, Norgen said, will be directed for use in settings with limited resources. The company will focus its development efforts on non-invasive, urine-based, rapid detection systems for diagnosing sexually transmitted infections and other diseases, such as tuberculosis.

Norgen added that it will be partnering with an unnamed Spanish diagnostic firm in the R&D work.

Based in Thorold, Ontario, Norgen is focused on developing sample preparation kits for DNA, RNA, and protein purification, and diagnostic tools.

"Such funding will help us in the transition of our powerful nucleic acid isolation technology into diagnostics applications," Yousef Haj-Ahmad, president and CEO of Norgen, said in a statement.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.